FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ronald DeConti

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Sreekanth Donepudi; Ronald C DeConti; Wolfram E Samlowski
Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
Ronald C DeConti
Chemotherapy of squamous cell carcinoma of the skin.
L Frank Glass; Ronald C DeConti; Vernon K Sondak
Introduction: Advanced cutaneous malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ronald DeConti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sreekanth Donepudi; Ronald C DeConti; Wolfram E Samlowski
Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
Seminars in oncology 2012;39(2):163-72.
2012: Ronald C DeConti
Chemotherapy of squamous cell carcinoma of the skin.
Seminars in oncology 2012;39(2):145-9.
2012: L Frank Glass; Ronald C DeConti; Vernon K Sondak
Introduction: Advanced cutaneous malignancies.
Seminars in oncology 2012;39(2):132-3.
2011: Athanassios Argiris; Rita S Axelrod; Barbara Burtness; Ronald C DeConti; Musie Ghebremichael; Arlene A Forastiere
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
Cancer 2011;117(15):3374-82.
2010: Wolfram E Samlowski; James Moon; Ralph J Tuthill; Michael C Heinrich; Naomi S Balzer-Haas; Stuart A Merl; Ronald C DeConti; John A Thompson; Merle T Witter; Lawrence E Flaherty; Vernon K Sondak
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).
American journal of clinical oncology 2010;33(5):495-9.
2009: Adil Daud; Jana Lynn Dawson; Ronald C DeConti; Elona Bicaku; Douglas C Marchion; Sem Bastien; FREDERICK HAUSHEER; Richard M Lush; Anthony Neuger; Daniel M Sullivan; Pamela N Munster
Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2479-87.
2008: Adil I Daud; Noweeda Mirza; Brianna Lenox; Stephanie Andrews; Patricia Urbas; Gui X Gao; Ji-Hyun Lee; vernon sondak; Adam I Riker; Ronald C DeConti; Dmitry I Gabrilovich
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3235-41.
2007: Malcolm S Mitchell; Judith Abrams; John A Thompson; Mohammed Kashani-Sabet; Ronald C DeConti; Wen-Jen Hwu; Michael B Atkins; Eric Whitman; Marc S Ernstoff; Frank G Haluska; James G Jakowatz; Tapas K Das Gupta; Jon M Richards; Wolfram E Samlowski; John J Costanzi; Frederick R Aronson; Albert B Deisseroth; Arkadiusz Z Dudek; Vicky E Jones
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2078-85.
2007: Pamela Münster; Douglas C Marchion; Elona Bicaku; Morgen Schmitt; Ji Hyun Lee; Ronald C DeConti; George Simon; Mayer Fishman; Susan Minton; Chris Garrett; Alberto Chiappori; Richard M Lush; Daniel Sullivan; Adil Daud
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):1979-85.
2006: Agop Bedikian; Michael Millward; Hubert Pehamberger; Robert Conry; Martin Gore; Uwe Trefzer; Anna C Pavlick; Ronald C DeConti; Evan M Hersh; Peter Hersey; John M Kirkwood; Frank G Haluska
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4738-45.
2006: Stephanie Andrews; Lary Robinson; Alan Cantor; Ronald C DeConti
Survival after surgical resection of isolated pulmonary metastases from malignant melanoma.
Cancer control : journal of the Moffitt Cancer Center 2006;13(3):218-23.
2005: Michael K Gibson; Yi Li; Barbara Murphy; Maha Hussain; Ronald C DeConti; John F Ensley; Arlene A Forastiere
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3562-7.
2005: Adil Daud; Nikola Valkov; Barbara Centeno; Jennifer Derderian; Patricia Sullivan; Pamela N Munster; Patricia Urbas; Ronald C DeConti; Elmer Berghorn; Zhenmei Liu; FREDERICK HAUSHEER; Daniel Sullivan
Phase II trial of karenitecin in patients with malignant melanoma: clinical and translational study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):3009-16.
2004: Corey J Langer; Yi Li; Timothy Jennings; Ronald C DeConti; Suresh Nair; Roger B Cohen; Arlene A Forastiere
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group.
Cancer investigation 2004;22(6):823-31.
2001: Arlene A Forastiere; T Leong; Eric K Rowinsky; B A Murphy; D R Vlock; Ronald C DeConti; G L Adams
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1088-95.
2000: D F Smith; Jane L Messina; R Perrott; Claudia Berman; Douglas S Reintgen; C Wayne Cruse; Frank Glass; Neil A Fenske; Ronald C DeConti; A Trotti
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma).
Cancer control : journal of the Moffitt Cancer Center 2000;7(1):72-83.
1999: William Flood; D J Lee; Andy Trotti; S Spencer; B Murphy; Fadlo R Khuri; Ronald C DeConti; R Wheeler; Arlene A Forastiere
Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.
Seminars in radiation oncology 1999;9(2 Suppl 1):64-9.
1998: Steve Shivers; X Wang; W Li; E Joseph; Jane L Messina; L Frank Glass; Ronald C DeConti; C Wayne Cruse; Claudia Berman; Neil A Fenske; GH Lyman; Douglas S Reintgen
Molecular staging of malignant melanoma: correlation with clinical outcome.
JAMA : the journal of the American Medical Association 1998;280(16):1410-5.
1998: Richard Heller; Mark J Jaroszeski; Douglas S Reintgen; Christopher A Puleo; Ronald C DeConti; Richard A Gilbert; L Frank Glass
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin.
Cancer 1998;83(1):148-57.
1998: Lluis M Mir; L Frank Glass; Gregor Sersa; Justin Teissié; Christian Domenge; Damijan Miklavcic; Mark J Jaroszeski; Stéphane Orlowski; Douglas S Reintgen; Zvonimir Rudolf; M Belehradek; Richard Gilbert; Marie-Pierre Rols; J Belehradek; Jean-Marc Bachaud; Ronald C DeConti; Borut Stabuc; Maja Cemazar; P Coninx; Richard Heller
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy.
British journal of cancer 1998;77(12):2336-42.
1998: Arlene A Forastiere; D Shank; D Neuberg; S G Taylor; Ronald C DeConti; G Adams
Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
Cancer 1998;82(11):2270-4.
1998: E Joseph; A Brobeil; Frank Glass; J Glass; Jane L Messina; Ronald C DeConti; C Wayne Cruse; DP Rapaport; Claudia Berman; Neil A Fenske; Douglas S Reintgen
Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes.
Annals of surgical oncology 1998;5(2):119-25.
1997: D Kamath; DP Rapaport; Ronald C DeConti; C Wayne Cruse; K Wells; Frank Glass; Jane L Messina; Neil A Fenske; A Brobeil; Claudia Berman; Christopher A Puleo; Douglas Reintgen
Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma.
The Journal of the Florida Medical Association 1997;84(3):182-7.
1997: D Kamath; A B Cantor; Frank Glass; Neil A Fenske; C Wayne Cruse; K Wells; DP Rapaport; Ronald C DeConti; Jane L Messina; Douglas Reintgen
Florida's undeclared epidemic: malignant melanoma.
The Journal of the Florida Medical Association 1997;84(3):161-5.
1997: A Brobeil; DP Rapaport; K Wells; C Wayne Cruse; Frank Glass; Neil A Fenske; J Albertini; G Miliotis; Jane L Messina; Ronald C DeConti; Claudia Berman; Alan R Shons; Alan Cantor; Douglas S Reintgen
Multiple primary melanomas: implications for screening and follow-up programs for melanoma.
Annals of surgical oncology 1997;4(1):19-23.
1996: Scot C Remick; M Chmura; C Bromberg; J Sporn; B Healey; J Hilstro; Ronald C DeConti; J Horton; John Ruckdeschel; G R Harper
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer.
American journal of clinical oncology 1996;19(2):125-31.
1996: Richard Heller; Mark J Jaroszeski; L Frank Glass; Jane L Messina; D P Rapaport; Ronald C DeConti; Neil A Fenske; Richard A Gilbert; Lluis M Mir; Douglas S Reintgen
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy.
Cancer 1996;77(5):964-71.
1996: J J Albertini; C Wayne Cruse; DP Rapaport; K Wells; M Ross; Ronald C DeConti; Claudia Berman; K Jared; Jane L Messina; GH Lyman; Frank Glass; Neil A Fenske; Douglas S Reintgen
Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.
Annals of surgery 1996;223(2):217-24.
1996: G Miliotes; J Albertini; Claudia Berman; Richard Heller; Jane L Messina; Frank Glass; W Cruse; DP Rapaport; Christopher A Puleo; Neil A Fenske; C Petsoglou; Ronald C DeConti; GH Lyman; Douglas Reintgen
The tumor biology of melanoma nodal metastases.
The American surgeon 1996;62(1):81-8.
1991: David H Johnson; John Ruckdeschel; J H Keller; G H Lyman; G J Kallas; J Macdonald; Ronald C DeConti; J Lee; Q S Ringenberg; W P Patterson
A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer.
Cancer 1991;67(1 Suppl):245-9.